Ashish A Kulkarni Selected Research

Colony-Stimulating Factor Receptors (Colony-Stimulating Factor Receptor)

12/2021

Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashish A Kulkarni Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 12/2013
1	Adenocarcinoma 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2016
1	Kidney Neoplasms (Kidney Cancer) 10/2016
1	Ovarian Neoplasms (Ovarian Cancer) 12/2013
1	Insulin Resistance 12/2013
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Renal Insufficiency (Renal Failure) 08/2010
1	Hemolytic-Uremic Syndrome 08/2010

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2020
1	OvalbuminIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	AntigensIBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 12/2021
1	Colony-Stimulating Factor Receptors (Colony-Stimulating Factor Receptor)IBA 12/2021
1	Granzymes (Granzyme)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Liposomes (Liposome)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 12/2013
1	Peptides (Polypeptides)IBA 12/2013
1	Shiga Toxins (Vero Toxin)IBA 08/2010

Therapy/Procedure

5	Immunotherapy 01/2023 - 10/2020
3	Therapeutics 01/2021 - 12/2013